Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

724 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer.
Brandão RD, Veeck J, Van de Vijver KK, Lindsey P, de Vries B, van Elssen CH, Blok MJ, Keymeulen K, Ayoubi T, Smeets HJ, Tjan-Heijnen VC, Hupperets PS. Brandão RD, et al. Among authors: de vries b. Breast Cancer Res. 2013 Apr 8;15(2):R29. doi: 10.1186/bcr3409. Breast Cancer Res. 2013. PMID: 23566419 Free PMC article. Clinical Trial.
A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer.
Schipper RJ, Moossdorff M, Nelemans PJ, Nieuwenhuijzen GA, de Vries B, Strobbe LJ, Roumen RM, van den Berkmortel F, Tjan-Heijnen VC, Beets-Tan RG, Lobbes MB, Smidt ML. Schipper RJ, et al. Among authors: de vries b. Clin Breast Cancer. 2014 Oct;14(5):315-22. doi: 10.1016/j.clbc.2013.12.015. Epub 2014 Jan 3. Clin Breast Cancer. 2014. PMID: 24548732
Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer.
Vriens BE, de Vries B, Lobbes MB, van Gastel SM, van den Berkmortel FW, Smilde TJ, van Warmerdam LJ, de Boer M, van Spronsen DJ, Smidt ML, Peer PG, Aarts MJ, Tjan-Heijnen VC; INTENS Study Group. Vriens BE, et al. Among authors: de boer m, de vries b. Eur J Cancer. 2016 Jan;52:67-76. doi: 10.1016/j.ejca.2015.10.010. Epub 2015 Nov 30. Eur J Cancer. 2016. PMID: 26650831 Clinical Trial.
Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study.
van Roozendaal LM, Smit LHM, Duijsens GHNM, de Vries B, Siesling S, Lobbes MBI, de Boer M, de Wilt JHW, Smidt ML. van Roozendaal LM, et al. Among authors: de boer m, de wilt jhw, de vries b. Breast Cancer Res Treat. 2016 Apr;156(3):465-472. doi: 10.1007/s10549-016-3757-4. Epub 2016 Mar 25. Breast Cancer Res Treat. 2016. PMID: 27013474 Free PMC article. Clinical Trial.
Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
van Roozendaal LM, Goorts B, Klinkert M, Keymeulen KBMI, De Vries B, Strobbe LJA, Wauters CAP, van Riet YE, Degreef E, Rutgers EJT, Wesseling J, Smidt ML. van Roozendaal LM, et al. Among authors: de vries b. Breast Cancer Res Treat. 2016 Apr;156(3):517-525. doi: 10.1007/s10549-016-3783-2. Epub 2016 Apr 15. Breast Cancer Res Treat. 2016. PMID: 27083179 Free PMC article.
Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
van Nijnatten TJA, Ploumen EH, Schipper RJ, Goorts B, Andriessen EH, Vanwetswinkel S, Schavemaker M, Nelemans P, de Vries B, Beets-Tan RGH, Smidt ML, Lobbes MBI. van Nijnatten TJA, et al. Among authors: de vries b. Eur J Radiol. 2016 Dec;85(12):2288-2294. doi: 10.1016/j.ejrad.2016.10.030. Epub 2016 Oct 28. Eur J Radiol. 2016. PMID: 27842679
724 results